2 results match your criteria: "inDNA Centre for Research and Innovation in Molecular Diagnostics[Affiliation]"
Editorial: Overcoming therapeutic resistance in head and neck squamous cell carcinoma.
Front Oncol
June 2025
inDNA Centre for Research and Innovation in Molecular Diagnostics, inDNA Life Sciences Private Limited, Bhubaneswar, Odisha, India.
Androgen Receptor Influenced Recurrence Score Correlation in Hormone Positive and HER2 Negative Breast Cancer Indian Patients: A Comparative Approach.
Genome Integr
July 2024
inDNA Centre for Research and Innovation in Molecular Diagnostics, inDNA Life Sciences Private Limited, Bhubaneswar, Odisha, India.
Breast cancer (BC) recurrence is a major concern for both patients and healthcare providers. Accurately predicting the risk of BC recurrence can help guide treatment decisions and improve patient outcomes for a disease-free survival. There are several approaches and models that have been developed to predict BC recurrence risk.
View Article and Find Full Text PDF